Detalles de la búsqueda
1.
Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma.
Invest New Drugs
; 27(5): 482-9, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19148579
2.
Randomized study of intravenous versus subcutaneous interleukin-2, and IFNalpha in patients with good prognosis metastatic renal cancer.
Clin Cancer Res
; 14(18): 5907-12, 2008 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18794104
3.
Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis, node-positive, early breast cancer: 10-year follow-up results of the French Adjuvant Study Group 05 randomized trial.
J Clin Oncol
; 23(12): 2686-93, 2005 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-15837983
4.
Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide.
J Clin Oncol
; 23(18): 4179-91, 2005 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-15961765
5.
Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, Investigational Drug Branch for Breast Cancer and the New Drug Development Group Study.
J Clin Oncol
; 22(13): 2576-86, 2004 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15226325
6.
Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial.
J Clin Oncol
; 22(23): 4622-30, 2004 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15505276
7.
Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin, as adjuvant therapy for node-positive breast cancer: French adjuvant study group.
J Clin Oncol
; 22(15): 3070-9, 2004 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15284257
8.
Randomized trial comparing six versus three cycles of epirubicin-based adjuvant chemotherapy in premenopausal, node-positive breast cancer patients: 10-year follow-up results of the French Adjuvant Study Group 01 trial.
J Clin Oncol
; 21(2): 298-305, 2003 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12525522
9.
Sensitivity and specificity of thallium-201 scintigraphy for the diagnosis of malignant vertebral fractures.
Eur J Radiol
; 51(3): 274-8, 2004 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15294337
10.
Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
J Clin Oncol
; 26(3): 421-7, 2008 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-18202419
11.
Epirubicin-based chemotherapy as adjuvant treatment for poor prognosis, node-negative breast cancer: 10-year follow-up results of the French Adjuvant Study Group 03 trial.
Bull Cancer
; 93(10): E109-14, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17074656
12.
Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy: ten-year results from the French Adjuvant Study Group GETIS 02 Trial.
Cancer
; 107(11): 2535-44, 2006 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17054108
13.
Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis.
Anticancer Drugs
; 17(10): 1211-7, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17075321
Resultados
1 -
13
de 13
1
Próxima >
>>